# DOXAZOSIN MESYLATE
> **ANDA212727** · Abbreviated New Drug Application (Generic) · Sponsor: RISING · Approved 2022-03-15
## Drug
- **FDA Application Number:** ANDA212727
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** DOXAZOSIN MESYLATE
- **Generic name:** DOXAZOSIN
- **Active ingredients:** DOXAZOSIN MESYLATE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** RISING
- **Manufacturer:** Rising Pharma Holdings, Inc.
- **First approval:** 2022-03-15
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212727)
---
*AI Analytics · CC0 1.0*